The Role of Portal Vein Thrombosis in the Clinical Course of Inflammatory Bowel Diseases: Report on Three Cases and Review of the Literature by Emanuele Sinagra, Emma Aragona, Claudia Romano, Simonetta Maisano, Ambrogio Orlando, Roberto Virdone, Lorenzo Tesè, Irene Modesto, Valeria Criscuoli, Mario Cottone

“…Inflammatory bowel diseases are associated with an increased risk of vascular complications. …”
Get full text

Expression Analysis of Fibronectin Type III Domain-Containing (FNDC) Genes in Inflammatory Bowel Disease and Colorectal Cancer by Tilo Wuensch, Jonas Wizenty, Janina Quint, Wolfgang Spitz, Madeleen Bosma, Olaf Becker, Andreas Adler, Wilfried Veltzke-Schlieker, Martin Stockmann, Sascha Weiss, Matthias Biebl, Johann Pratschke, Felix Aigner

“…FNDC4 was described as anti-inflammatory factor, upregulated in inflammatory bowel disease (IBD). FNDC signaling includes direct cell-cell interaction as well as release of bioactive peptides, like shown for FNDC4 or FNDC5. …”
Get full text

Inflammatory Bowel Diseases and Irritable Bowel Syndrome: Overlap of Two Nosological Forms or Two Variants of the Same Disease? by A. A. Sheptulin, K. E. Vinogradskaya

Subjects: “…inflammatory bowel disease…”
Get full text

Diagnostic interval of inflammatory bowel disease in Chinese children and its relationship with growth parameters: a retrospective study by Juan Zhou, BinRong Chen, ZhiCheng Wang, Li Liu, HongJuan OuYang, YanHong Luo, WenTing Zhang, ChenXi Liu, MeiZheng Zhan, JiaQi Duan, CanLin Li, Na Jiang, JieYu You, HongMei Zhao

Subjects: “…inflammatory bowel disease…”
Get full text

Novel anti-inflammatory properties of mannose oligosaccharides in the treatment of inflammatory bowel disease via LGALS3 modulation by Yaqi Du, Yan Fan, Xin Li, Fenqin Chen

“…Abstract This study investigates the role of Gum Arabic Mannose Oligosaccharides (GA-MOS) in modulating gut microbiota and alleviating symptoms of Inflammatory Bowel Disease (IBD). Employing both in vitro and in vivo models, we explored how GA-MOS influences microbial communities, particularly focusing on their capacity to enhance health-associated bacteria and reduce pathogenic species within the gut environment. …”
Get full text

N-acetyltransferase 2 Slow Acetylator Genotype Associated with Adverse Effects of Sulfasalazine in the Treatment of Inflammatory Bowel Disease by Min Chen, Bing Xia, Bixiao Chen, Qiusha Guo, Jin Li, Mei Ye, Zhengguo Hu

“…The aim of the present study was to investigate associations of the genotypes of NAT2 with inflammatory bowel disease (IBD), and with adverse effects of SASP, which is used as the first-line treatment of IBD.…”
Get full text

Cardiovascular safety of Janus kinase inhibitors in inflammatory bowel disease: a systematic review and network meta-analysis by Huibin Yang, Ting An, Yuxuan Zhao, Xiaojing Shi, Bangmao Wang, Qingyu Zhang

Subjects: “…Inflammatory bowel disease…”
Get full text

The Role of Vitamin D in the Pathomechanism of Inflammatory Bowel Disease (IBD) and its Therapeutic Implications - a literature review by Wiktoria Maria Tomaszewska, Paweł Siudziński, Mateusz Łyko, Alicja Skoczylas, Jakub Kurasz, Wojciech Maj, Wiktoria Podlasiewicz, Katarzyna Pala, Piotr Dudziak, Anna Nowak, Maria Golińska

Subjects: “…Inflammatory bowel diseases (IBD)…”
Get full text

Evaluation of Serum Leucine-Rich Alpha-2 Glycoprotein as a New Inflammatory Biomarker of Inflammatory Bowel Disease by Tetsuhiro Yoshimura, Keiichi Mitsuyama, Ryosuke Sakemi, Hidetoshi Takedatsu, Shinichiro Yoshioka, Kotaro Kuwaki, Atsushi Mori, Shuhei Fukunaga, Toshihiro Araki, Masaru Morita, Kozo Tsuruta, Hiroshi Yamasaki, Takuji Torimura

“…Studies on serum leucine-rich alpha-2 glycoprotein (LRG) in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn’s disease (CD), are scarce; the methods for estimating disease activity are less established, particularly for CD. …”
Get full text

Examining endothelial function and carotid artery disease in patients with inflammatory bowel disease: a systematic review protocol by Hao Wu, Zhenguo Liu, Tingzi Hu, Meihua Xu, Hong Hao, Michael A Hill, Canxia Xu

“…Introduction Patients with inflammatory bowel disease (IBD) might be at an increased risk for the development of cardiovascular disease (CVD). …”
Get full text

Ophthalmological manifestations in inflammatory bowel disease under the watchful eye of a gastroenterologist from a tertiary centre by Konrad Lewandowski, Magdalena Kaniewska, Katarzyna Karłowicz, Martyna Więcek, Edyta Tulewicz-Marti, Piotr Celmer, Małgorzata Frankowska, Joanna Sempińska-Szewczyk, Grażyna Rydzewska

Subjects: Get full text

What Made Canada Become a Country with the Highest Incidence of Inflammatory Bowel Disease: Could Sucralose be the Culprit? by Xiaofa Qin

Get full text

High Intestinal and Systemic Levels of Interleukin-23/T-Helper 17 Pathway in Chinese Patients with Inflammatory Bowel Disease by Lu Song, Rui Zhou, Sha Huang, Feng Zhou, Shufang Xu, Wei Wang, Fengming Yi, Xiaobing Wang, Bing Xia

“…Interleukin-23/T-helper 17 (IL-23/Th17) pathway plays a key role in the pathogenesis of inflammatory bowel disease (IBD), but little is known about its expression in Chinese population. …”
Get full text

Interobserver Agreement in the Diagnosis of Inflammatory Bowel Disease-Associated Neoplasia in China in Comparison to Subspecialized American Gastrointestinal Pathologists by Xian-rui Wu, Hua-shan Liu, Xue-ying Shi, Wei-xun Zhou, Zhi-nong Jiang, Yan Huang, Dipti M. Karamchandani, John R. Goldblum, Shu-yuan Xiao, Hong-fa Zhu, Michael M. Feely, Amy L. Collinsworth, Ashwini Esnakula, Hao Xie, Bo Shen, Ping Lan, Xiu-li Liu

“…The aim of this study was to evaluate the interobserver variability in diagnosing inflammatory bowel disease (IBD)-associated neoplasia among practicing pathologists from China using telepathology, a practice of remote diagnostic consultation increasingly used nationally and internationally, and its comparison with the interpretation of subspecialized gastrointestinal (GI) pathologists from the United States (US). …”
Get full text

Self-Reported Awareness and Use of International Classification of Disease Coding of Inflammatory Bowel Disease Services by Ontario Physicians by Forough Farrokhyar, Kevin McHugh, E Jan Irvine

Get full text

Management of the Pregnant Inflammatory Bowel Disease Patient on Antitumour Necrosis Factor Therapy: State of the Art and Future Directions by Yvette PY Leung, Remo Panaccione, Subrata Ghosh, Cynthia H Seow

“…Antitumour necrosis factor (anti-TNF) therapy has been a major advance in the treatment of inflammatory bowel disease (IBD) by improving rates of mucosal healing, steroid-free remission, and decreasing rates of hospitalization and surgery. …”
Get full text

Oxidative and Antioxidative Stress Status in Children with Inflammatory Bowel Disease as a Result of a Chronic Inflammatory Process by Urszula Grzybowska-Chlebowczyk, Paulina Wysocka-Wojakiewicz, Martyna Jasielska, Bożena Cukrowska, Sabina Więcek, Maria Kniażewska, Jerzy Chudek

“…Oxidative stress (OS) has been recently implicated in the disease pathogenesis in inflammatory bowel disease (IBD). The aim of the study was to evaluate oxidative and antioxidative stress status and the risk of the atherosclerotic process in children with IBD and functional gastrointestinal disorders (FGID). …”
Get full text

Biological characteristics, immune infiltration and drug prediction of PANoptosis related genes and possible regulatory mechanisms in inflammatory bowel disease by Minglin Zhang, Tong Liu, Lijun Luo, Yuxin Xie, Fen Wang

Subjects: Get full text

Anti-Tumor Necrosis Factor-α Use in Pediatric Inflammatory Bowel Disease—Reports from a Romanian Center by Roxana Matran, Andra-Mihaela Diaconu, Andreea Maria Iordache, Irina Dijmărescu, Alexandra Coroleucă, Daniela Păcurar, Cristina Becheanu

Subjects: “…inflammatory bowel disease…”
Get full text

Very Early-Onset Inflammatory Bowel Disease (VEO-IBD) Presenting with Recurrent Leukocytoclastic Vasculitis Preceded by Streptococcal Pharyngitis by Ashley Fonseca, Julee Sunny, Lina M. Felipez

“…Inflammatory bowel disease (IBD) that presents in children <6 years of age is known as very early-onset IBD (VEO-IBD). …”
Get full text